Quantum-Si, Inc. (QSI)
0.8056
+0.02
(+1.90%)
USD |
NASDAQ |
Aug 27, 16:00
0.8056
0.00 (0.00%)
After-Hours: 20:00
Quantum-Si Enterprise Value : 64.56M for Aug. 26, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 26, 2026 | 64.56M |
| August 25, 2026 | 76.97M |
| August 24, 2026 | 59.90M |
| August 21, 2026 | 74.28M |
| August 20, 2026 | 62.24M |
| August 19, 2026 | 60.07M |
| August 18, 2026 | 50.86M |
| August 17, 2026 | 54.41M |
| August 14, 2026 | 53.44M |
| August 13, 2026 | 64.43M |
| August 12, 2026 | 74.81M |
| August 11, 2026 | 71.04M |
| August 10, 2026 | 64.45M |
| August 07, 2026 | 69.77M |
| August 06, 2026 | 56.77M |
| August 05, 2026 | 57.10M |
| August 04, 2026 | 59.05M |
| August 03, 2026 | 54.80M |
| July 31, 2026 | 47.44M |
| July 30, 2026 | 49.11M |
| July 29, 2026 | 45.23M |
| July 28, 2026 | 58.00M |
| July 27, 2026 | 62.99M |
| July 24, 2026 | 60.07M |
| July 23, 2026 | 64.43M |
| Date | Value |
|---|---|
| July 22, 2026 | 66.62M |
| July 21, 2026 | 74.50M |
| July 20, 2026 | 70.34M |
| July 17, 2026 | 71.52M |
| July 16, 2026 | 70.84M |
| July 15, 2026 | 80.19M |
| July 14, 2026 | 81.11M |
| July 13, 2026 | 81.79M |
| July 10, 2026 | 84.72M |
| July 09, 2026 | 102.17M |
| July 08, 2026 | 91.29M |
| July 07, 2026 | 92.78M |
| July 06, 2026 | 99.82M |
| July 02, 2026 | 95.16M |
| July 01, 2026 | 93.78M |
| June 30, 2026 | 85.22M |
| June 29, 2026 | 69.40M |
| June 26, 2026 | 62.00M |
| June 25, 2026 | 62.54M |
| June 24, 2026 | 56.00M |
| June 23, 2026 | 67.47M |
| June 22, 2026 | 76.42M |
| June 18, 2026 | 93.31M |
| June 17, 2026 | 81.43M |
| June 16, 2026 | 83.54M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Champions Oncology, Inc. | 68.18M |
| Medpace Holdings, Inc. | 16.88B |
| Avantor, Inc. | 13.20B |
| Personalis, Inc. | 1.642B |
| Adaptive Biotechnologies Corp. | 4.235B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -23.53M |
| Revenue (Quarterly) | 0.344M |
| Total Expenses (Quarterly) | 23.88M |
| EPS Diluted (Quarterly) | -0.108 |
| Gross Profit Margin (Quarterly) | -298.8% |
| Profit Margin (Quarterly) | -6.84K% |
| Earnings Yield | -57.49% |
| Normalized Earnings Yield | -52.16 |